Journal of the American Chemical Society · 2023 · 35 citations · 53 references
PharmacyChemical BiologyMedicinal ChemistryDrug DeliveryDrug DiscoveryHost-pathogen InteractionsAntibacterial PharmacologyAntibiotic ResistanceIntracellular Drug TargetsTargeted Antimicrobial TherapyAntibiotic DiscoveryEndosome-endosome FusionIntracellular PersistenceNovel Antibacterial Drug DiscoveryPeptidomimetic ModulatorsPhagolysosome FusionPhagosome FusionSubcellular Targeting
Intracellular bacterial pathogens, such as Staphylococcus aureus, that may hide in intracellular vacuoles represent the most significant manifestation of bacterial persistence. They are critically associated with chronic infections and antibiotic resistance, as conventional antibiotics are ineffective against such intracellular persisters due to permeability issues and mechanistic reasons. Direct subcellular targeting of S. aureus vacuoles suggests an explicit opportunity for the eradication of these persisters, but a comprehensive understanding of the chemical biology nature and significance of precise S. aureus vacuole targeting remains limited. Here, we report an oligoguanidine-based peptidomimetic that effectively targets and eradicates intracellular S. aureus persisters in the phagolysosome lumen, and this oligomer was utilized to reveal the mechanistic insights linking precise targeting to intracellular antimicrobial efficacy. The oligomer has high cellular uptake via a receptor-mediated endocytosis pathway and colocalizes with S. aureus persisters in phagolysosomes as a result of endosome–lysosome interconversion and lysosome–phagosome fusion. Moreover, the observation of a bacterium’s altered susceptibility to the oligomer following a modification in its intracellular localization offers direct evidence of the critical importance of precise intracellular targeting. In addition, eradication of intracellular S. aureus persisters was achieved by the oligomer’s membrane/DNA dual-targeting mechanism of action; therefore, its effectiveness is not hampered by the hibernation state of the persisters. Such precise subcellular targeting of S. aureus vacuoles also increases the agent’s biocompatibility by minimizing its interaction with other organelles, endowing excellent in vivo bacterial targeting and therapeutic efficacy in animal models.
53
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Michael A. Kohanski, Daniel J. Dwyer, Boris Hayete et al. · Cell · 2007 · 3K citations · Full text
Antibiotic tolerance facilitates the evolution of resistance
Irit Levin-Reisman, Irine Ronin, Orit Gefen et al. · Science · 2017 · 1.3K citations · Full text
Predictive compound accumulation rules yield a broad-spectrum antibiotic
Michelle F. Richter, Bryon Drown, Andrew P. Riley et al. · Nature · 2017 · 886 citations
Novel antibody–antibiotic conjugate eliminates intracellular S. aureus
Sophie M. Lehar, Thomas H. Pillow, Min Xu et al. · Nature · 2015 · 833 citations